Globus Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Globus Medical
GMED Stock  USD 71.59  0.55  0.76%   
Globus Medical financial statements provide useful quarterly and yearly information to potential Globus Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Globus Medical financial statements helps investors assess Globus Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Globus Medical's valuation are summarized below:
Gross Profit
1.7 B
Profit Margin
0.0409
Market Capitalization
9.9 B
Enterprise Value Revenue
3.7383
Revenue
2.5 B
There are over one hundred nineteen available fundamental trends for Globus Medical, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Globus Medical's regular performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road.

Globus Medical Total Revenue

2.65 Billion

Check Globus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Globus Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 266.7 M, Interest Expense of 24.3 M or Total Revenue of 2.6 B, as well as many indicators such as Price To Sales Ratio of 4.13, Dividend Yield of 0.0 or PTB Ratio of 3.89. Globus financial statements analysis is a perfect complement when working with Globus Medical Valuation or Volatility modules.
  
Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Globus Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding106.9 M137.9 M99.5 M
Slightly volatile
Total Assets5.5 B5.3 B1.8 B
Slightly volatile
Short and Long Term Debt Total564 M537.2 M104.1 M
Slightly volatile
Other Current Liabilities763.8 M727.4 M159.7 M
Slightly volatile
Total Current Liabilities898.7 M855.9 M205.5 M
Slightly volatile
Total Stockholder Equity4.4 B4.2 B1.5 B
Slightly volatile
Other Liabilities85.2 M81.1 M38.3 M
Slightly volatile
Property Plant And Equipment Net642.1 M611.6 M226.8 M
Slightly volatile
Current Deferred Revenue11.4 M22.1 M7.1 M
Slightly volatile
Retained Earnings798.2 M1.2 B730.2 M
Slightly volatile
Accounts Payable78.9 M75.1 M28.5 M
Slightly volatile
Cash823.7 M784.4 M246.5 M
Slightly volatile
Non Current Assets Total3.2 B3.1 B986.3 M
Slightly volatile
Other Assets111.3 M106 M52.8 M
Slightly volatile
Cash And Short Term Investments934.6 M890.1 M386.8 M
Slightly volatile
Net Receivables585.6 M557.7 M193.7 M
Slightly volatile
Common Stock Total Equity102.5 K115 K95.5 K
Slightly volatile
Liabilities And Stockholders Equity5.5 B5.3 B1.8 B
Slightly volatile
Non Current Liabilities Total578.4 M550.8 M139.4 M
Slightly volatile
Inventory692.2 M659.2 M245.7 M
Slightly volatile
Other Current Assets73.8 M70.3 M20.6 M
Slightly volatile
Other Stockholder Equity3.2 B3 B793.9 M
Slightly volatile
Total Liabilities1.1 B1.1 B302.3 M
Slightly volatile
Property Plant And Equipment Gross1.2 B1.2 B363.9 M
Slightly volatile
Total Current Assets2.3 B2.2 B860.6 M
Slightly volatile
Short Term Debt30.3 M20.5 M22.8 M
Slightly volatile
Common Stock108.8 K137 K99.6 K
Slightly volatile
Property Plant Equipment146.5 M280.3 M150.1 M
Slightly volatile
Good Will1.5 B1.4 B349.1 M
Slightly volatile
Intangible Assets834.9 M795.1 M200.1 M
Slightly volatile
Net Tangible Assets981.4 M1.8 B932.9 M
Slightly volatile
Capital Surpluse761.9 M725.6 M363.5 M
Slightly volatile
Non Current Liabilities Other116.6 M111 M41.3 M
Slightly volatile
Long Term Investments62.8 M66.1 M167.5 M
Slightly volatile
Deferred Long Term Asset Charges17.1 M12.2 M21.6 M
Slightly volatile
Net Invested Capital2.4 B4.6 B1.7 B
Slightly volatile
Net Working Capital925.6 M1.3 B709.3 M
Slightly volatile
Capital Stock121 K137 K104.7 K
Slightly volatile
Capital Lease Obligations74.4 M93.8 M21.8 M
Slightly volatile
Short and Long Term Debt354.7 M399 M435 M
Slightly volatile

Globus Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization266.7 M254 M72.5 M
Slightly volatile
Total Revenue2.6 B2.5 B914.2 M
Slightly volatile
Gross Profit1.6 B1.5 B630.1 M
Slightly volatile
Other Operating Expenses2.5 B2.4 B762.6 M
Slightly volatile
Operating Income155.5 M166 M145.6 M
Slightly volatile
EBIT170.8 M219.7 M160.1 M
Slightly volatile
Research Development171.9 M163.8 M67.9 M
Slightly volatile
EBITDA497.4 M473.7 M236.4 M
Slightly volatile
Cost Of Revenue1.1 B1 B284.1 M
Slightly volatile
Total Operating Expenses1.4 B1.3 B478.5 M
Slightly volatile
Income Before Tax160.6 M120.7 M150.5 M
Slightly volatile
Net Income117.1 M103 M110.3 M
Slightly volatile
Income Tax Expense31.5 M17.7 M39.3 M
Pretty Stable
Selling General Administrative1 B981 M379.2 M
Slightly volatile
Net Income Applicable To Common Shares120.8 M218.7 M122.4 M
Slightly volatile
Net Income From Continuing Ops130.2 M103 M113.5 M
Slightly volatile
Tax Provision32.8 M17.7 M46.5 M
Slightly volatile
Interest Income21.1 M20.1 M9.6 M
Slightly volatile
Reconciled Depreciation266.7 M254 M81.1 M
Slightly volatile

Globus Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation56.9 M54.2 M22.6 M
Slightly volatile
Free Cash Flow425.5 M405.2 M139 M
Slightly volatile
Begin Period Cash Flow490.7 M467.3 M175.4 M
Slightly volatile
Depreciation266.7 M254 M72.2 M
Slightly volatile
Other Non Cash Items247.1 M235.3 M50.7 M
Slightly volatile
Capital Expenditures121.2 M115.4 M56.5 M
Slightly volatile
Total Cash From Operating Activities546.7 M520.6 M195.6 M
Slightly volatile
Net Income117.3 M103 M110.5 M
Slightly volatile
End Period Cash Flow823.7 M784.4 M242.7 M
Slightly volatile
Issuance Of Capital Stock56.7 M73 M48.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.134.45595.201
Slightly volatile
PTB Ratio3.892.68733.5583
Pretty Stable
Days Sales Outstanding55.4180.798268.3931
Slightly volatile
Book Value Per Share32.3230.777714.0364
Slightly volatile
Free Cash Flow Yield0.03590.03610.0311
Pretty Stable
Operating Cash Flow Per Share4.033.83591.8126
Slightly volatile
Stock Based Compensation To Revenue0.01780.02150.0224
Slightly volatile
Capex To Depreciation0.430.45441.1542
Slightly volatile
PB Ratio3.892.68733.5583
Pretty Stable
EV To Sales3.974.35774.8988
Slightly volatile
Free Cash Flow Per Share3.132.98551.2747
Slightly volatile
ROIC0.03050.03210.1126
Slightly volatile
Inventory Turnover1.31.57071.1847
Slightly volatile
Net Income Per Share0.870.75881.1012
Slightly volatile
Days Of Inventory On Hand261232323
Slightly volatile
Payables Turnover14.4713.78478.792
Slightly volatile
Sales General And Administrative To Revenue0.450.50.4318
Slightly volatile
Research And Ddevelopement To Revenue0.0610.0650.0755
Pretty Stable
Capex To Revenue0.07650.04580.0716
Pretty Stable
Cash Per Share6.896.55773.66
Slightly volatile
POCF Ratio19.4321.561824.6418
Pretty Stable
Interest Coverage11.3414.4110.2583
Slightly volatile
Capex To Operating Cash Flow0.370.22170.3476
Slightly volatile
PFCF Ratio49.2327.70446.7866
Pretty Stable
Days Payables Outstanding51.3626.478646.9782
Slightly volatile
Income Quality5.315.05551.7933
Slightly volatile
ROE0.02340.02470.12
Slightly volatile
EV To Operating Cash Flow17.9521.086922.1567
Slightly volatile
PE Ratio11410942.2395
Slightly volatile
Return On Tangible Assets0.03240.03410.1194
Slightly volatile
EV To Free Cash Flow26.6627.093832.9086
Slightly volatile
Earnings Yield0.00870.00920.0336
Slightly volatile
Intangibles To Total Assets0.450.42410.1826
Slightly volatile
Current Ratio2.422.54386.1037
Slightly volatile
Tangible Book Value Per Share7.2614.36598.9579
Slightly volatile
Receivables Turnover6.024.51745.5057
Slightly volatile
Graham Number13.722.922516.9031
Slightly volatile
Shareholders Equity Per Share32.3230.777714.0364
Slightly volatile
Debt To Equity0.140.12860.0279
Slightly volatile
Capex Per Share0.890.85050.5373
Slightly volatile
Graham Net Net2.724.1523.3565
Slightly volatile
Revenue Per Share19.4918.56218.4085
Slightly volatile
Interest Debt Per Share4.163.95790.847
Slightly volatile
Debt To Assets0.110.10230.0223
Slightly volatile
Enterprise Value Over EBITDA13.8523.175117.0948
Slightly volatile
Short Term Coverage Ratios25.7445.7246.5885
Very volatile
Price Earnings Ratio11410942.2395
Slightly volatile
Operating Cycle317313391
Slightly volatile
Price Book Value Ratio3.892.68733.5583
Pretty Stable
Days Of Payables Outstanding51.3626.478646.9782
Slightly volatile
Price To Operating Cash Flows Ratio19.4321.561824.6418
Pretty Stable
Price To Free Cash Flows Ratio49.2327.70446.7866
Pretty Stable
Pretax Profit Margin0.04550.04790.2245
Slightly volatile
Ebt Per Ebit0.820.72731.0203
Very volatile
Operating Profit Margin0.06260.06590.2185
Slightly volatile
Effective Tax Rate0.140.14690.2675
Slightly volatile
Company Equity Multiplier0.931.25721.1437
Pretty Stable
Long Term Debt To Capitalization0.080.1120.0947
Very volatile
Total Debt To Capitalization0.120.11390.0248
Slightly volatile
Return On Capital Employed0.03590.03780.1645
Slightly volatile
Debt Equity Ratio0.140.12860.0279
Slightly volatile
Ebit Per Revenue0.06260.06590.2185
Slightly volatile
Quick Ratio1.681.77364.688
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.74.51053.1735
Pretty Stable
Net Income Per E B T0.570.85310.7118
Slightly volatile
Cash Ratio0.870.91651.8858
Slightly volatile
Cash Conversion Cycle279287345
Slightly volatile
Operating Cash Flow Sales Ratio0.180.20670.2154
Very volatile
Days Of Inventory Outstanding261232323
Slightly volatile
Days Of Sales Outstanding55.4180.798268.3931
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.530.77830.6461
Pretty Stable
Cash Flow Coverage Ratios0.920.969247.847
Slightly volatile
Price To Book Ratio3.892.68733.5583
Pretty Stable
Fixed Asset Turnover5.364.11964.9003
Slightly volatile
Capital Expenditure Coverage Ratio2.74.51053.1735
Pretty Stable
Price Cash Flow Ratio19.4321.561824.6418
Pretty Stable
Enterprise Value Multiple13.8523.175117.0948
Slightly volatile
Debt Ratio0.110.10230.0223
Slightly volatile
Cash Flow To Debt Ratio0.920.969247.847
Slightly volatile
Price Sales Ratio4.134.45595.201
Slightly volatile
Return On Assets0.01860.01960.1042
Slightly volatile
Asset Turnover0.70.47970.6402
Slightly volatile
Net Profit Margin0.03880.04090.1579
Slightly volatile
Gross Profit Margin0.830.5890.7552
Slightly volatile
Price Fair Value3.892.68733.5583
Pretty Stable
Return On Equity0.02340.02470.12
Slightly volatile

Globus Fundamental Market Drivers

Forward Price Earnings20.6612
Cash And Short Term Investments890.1 M

Globus Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Globus Medical Financial Statements

Globus Medical stakeholders use historical fundamental indicators, such as Globus Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Globus Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Globus Medical's assets and liabilities are reflected in the revenues and expenses on Globus Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Globus Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue22.1 M11.4 M
Total Revenue2.5 B2.6 B
Cost Of Revenue1 B1.1 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.50  0.45 
Research And Ddevelopement To Revenue 0.06  0.06 
Capex To Revenue 0.05  0.08 
Revenue Per Share 18.56  19.49 
Ebit Per Revenue 0.07  0.06 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
How To Invest In Globus
Details
Is Globus Stock a good investment?
Details
What is Globus Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.827
Earnings Share
0.75
Revenue Per Share
18.562
Quarterly Revenue Growth
0.066
Return On Assets
0.0533
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY